Equities analysts expect Stericycle Inc (NASDAQ:SRCL) to post $1.13 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Seven analysts have provided estimates for Stericycle’s earnings, with estimates ranging from $1.09 to $1.15. Stericycle reported earnings per share of $1.15 in the same quarter last year, which would suggest a negative year over year growth rate of 1.7%. The company is expected to report its next quarterly earnings report after the market closes on Thursday, August 2nd.

On average, analysts expect that Stericycle will report full year earnings of $4.63 per share for the current financial year, with EPS estimates ranging from $4.48 to $4.70. For the next year, analysts anticipate that the firm will report earnings of $4.78 per share, with EPS estimates ranging from $4.63 to $4.96. Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Stericycle.

Stericycle (NASDAQ:SRCL) last posted its earnings results on Thursday, May 3rd. The business services provider reported $1.21 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.05 by $0.16. The business had revenue of $895.00 million during the quarter, compared to analyst estimates of $880.48 million. Stericycle had a return on equity of 14.14% and a net margin of 0.19%. The company’s quarterly revenue was up .3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.09 EPS.

SRCL has been the subject of a number of recent analyst reports. Zacks Investment Research raised Stericycle from a “hold” rating to a “buy” rating and set a $73.00 target price for the company in a report on Friday, July 6th. BidaskClub raised Stericycle from a “hold” rating to a “buy” rating in a report on Tuesday, April 24th. ValuEngine lowered Stericycle from a “sell” rating to a “strong sell” rating in a report on Wednesday, May 2nd. BMO Capital Markets boosted their price objective on Stericycle from $64.00 to $67.00 and gave the stock a “market perform” rating in a report on Friday, May 4th. Finally, Barrington Research reissued a “buy” rating on shares of Stericycle in a report on Friday, June 1st. Two analysts have rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $77.13.

Stericycle traded up $0.42, reaching $67.23, during mid-day trading on Friday, Marketbeat.com reports. 86,221 shares of the company traded hands, compared to its average volume of 679,629. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 0.88. The firm has a market capitalization of $5.69 billion, a PE ratio of 15.46, a PEG ratio of 1.49 and a beta of 0.41. Stericycle has a 52-week low of $56.64 and a 52-week high of $83.25.

In other news, Director Thomas D. Brown sold 13,210 shares of the business’s stock in a transaction dated Wednesday, May 16th. The stock was sold at an average price of $63.37, for a total transaction of $837,117.70. Following the completion of the transaction, the director now owns 14,705 shares of the company’s stock, valued at $931,855.85. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Charles A. Alutto sold 14,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 22nd. The stock was sold at an average price of $64.02, for a total value of $896,280.00. Following the completion of the sale, the chief executive officer now owns 18,026 shares of the company’s stock, valued at approximately $1,154,024.52. The disclosure for this sale can be found here. Insiders have sold 207,375 shares of company stock valued at $13,411,695 in the last three months. 3.50% of the stock is owned by insiders.

A number of large investors have recently added to or reduced their stakes in SRCL. Zions Bancorporation bought a new stake in Stericycle in the 1st quarter worth approximately $122,000. Federated Investors Inc. PA lifted its position in Stericycle by 129.5% in the 1st quarter. Federated Investors Inc. PA now owns 2,088 shares of the business services provider’s stock worth $122,000 after buying an additional 1,178 shares during the last quarter. Allianz Asset Management GmbH bought a new stake in Stericycle in the 4th quarter worth approximately $229,000. Massmutual Trust Co. FSB ADV lifted its position in Stericycle by 27.7% in the 1st quarter. Massmutual Trust Co. FSB ADV now owns 3,904 shares of the business services provider’s stock worth $229,000 after buying an additional 847 shares during the last quarter. Finally, Two Sigma Securities LLC bought a new stake in Stericycle in the 4th quarter worth approximately $244,000. Institutional investors own 97.56% of the company’s stock.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services.

Get a free copy of the Zacks research report on Stericycle (SRCL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.